CHARLESTON, WV (LOOTPRESS) – As the fall season progresses, the West Virginia Department of Health is calling on residents to remain alert in the face of rising respiratory illnesses, including flu, COVID-19, and respiratory syncytial virus (RSV).
In response to these ongoing health threats, department of health has updated its Pan Respiratory Dashboard to now track cases of RSV and flu, alongside COVID-19, allowing residents to assess their risk more effectively.
This year’s respiratory season brings new advancements in vaccine technology. The Food and Drug Administration (FDA) has approved updated COVID-19 vaccines, tailored to protect against newer variants.
In addition, three RSV vaccines are now available for adults aged 60 and older, aimed at preventing severe RSV infections and reducing hospitalizations.
For infants, the RSV monoclonal antibody, Beyfortus, has been available since July 2023, offering vital protection for those under eight months.
Pregnant women are also advised to receive a single dose of the maternal RSV vaccine (Pfizer’s Abrysvo) between weeks 32 and 36 of pregnancy, ideally between September and January.
“Vaccination remains one of our most effective tools in reducing severe illness and hospitalization from respiratory viruses,” said Dr. Sherri Young, Secretary of the Department of Health.
While widespread vaccination has lessened the threat of severe COVID-19 outcomes, Dr. Young stated that new variants continue to pose risks, particularly to those who are unvaccinated, elderly, or have underlying health conditions.
Residents are encouraged to stay informed and take advantage of these preventive measures as respiratory viruses continue to spread.
For more information on how to stay safe and healthy this season, click here.
